Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01184625|
Recruitment Status : Unknown
Verified June 2011 by Karolinska Institutet.
Recruitment status was: Recruiting
First Posted : August 19, 2010
Last Update Posted : June 27, 2011
|Condition or disease||Intervention/treatment|
|Myositis||Other: Physical Exercise|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation|
|Study Start Date :||January 2008|
|Estimated Primary Completion Date :||January 2012|
|Estimated Study Completion Date :||August 2012|
U.S. FDA Resources
Other: Physical Exercise
12 weeks of physical exercise.
No Intervention: No intervention
12 weeks of stable physical exercise level.
- Hypoxia related metabolites. [ Time Frame: At baseline before intervention. ]
- Hypoxia related metabolites. [ Time Frame: After 12 weeks of endurance exercise intervention/ non intervention. ]
- Muscle impairment. [ Time Frame: At baseline before intervention. ]
- Muscle impairment. [ Time Frame: After 12 weeks of endurance exercise intervention/ non intervention. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01184625
|Contact: Ingrid E Lundberg, MD, PhD, Prof||+46 8 517700 ext email@example.com|
|Rheumatology unit, Karolinska University Hospital||Recruiting|
|Contact: Ingrid E Lundberg, MD, PhD, Prof +46 8 517700 ext 6087 firstname.lastname@example.org|
|Principal Investigator:||Ingrid E Lundberg, MD, PhD, Prof||Rheumatology Unit, Department of Medicine, in Solna, Karolinska Institutet|